Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renske Keeman

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2023
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and SurvivalJosephine M N Lopes Cardozo, Irene L Andrulis, Stig E Bojesen, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literatureAmber N Hurson, Thomas U Ahearn, Hela Koka, et al.
Journal of the National Cancer Institute|July 17, 2024
Risk factors for breast cancer subtypes by race and ethnicity: a scoping reviewAmber N Hurson, Thomas U Ahearn, Hela Koka, et al.
International Journal of Cancer|March 2, 2018
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferationMustapha Abubakar, Jenny Chang-Claude, H Raza Ali, et al.
Drug and Alcohol Dependence|May 15, 2018
Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco useAndries T Marees, Anke R Hammerschlag, Lisa Bastarache, et al.
Breast Cancer Research : BCR|October 22, 2022
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patientsDaniele Giardiello, Maartje J Hooning, Michael Hauptmann, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2023
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and SurvivalJosephine M N Lopes Cardozo, Irene L Andrulis, Stig E Bojesen, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Risk factors for breast cancer subtypes by race and ethnicity: A scoping review of the literatureAmber N Hurson, Thomas U Ahearn, Hela Koka, et al.
Journal of the National Cancer Institute|July 17, 2024
Risk factors for breast cancer subtypes by race and ethnicity: a scoping reviewAmber N Hurson, Thomas U Ahearn, Hela Koka, et al.
International Journal of Cancer|March 2, 2018
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferationMustapha Abubakar, Jenny Chang-Claude, H Raza Ali, et al.
Drug and Alcohol Dependence|May 15, 2018
Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco useAndries T Marees, Anke R Hammerschlag, Lisa Bastarache, et al.
Breast Cancer Research : BCR|October 22, 2022
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patientsDaniele Giardiello, Maartje J Hooning, Michael Hauptmann, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
International Journal of Epidemiology|January 10, 2018
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association ConsortiumAnja Rudolph, Minsun Song, Mark N Brook, et al.
Genome Medicine|May 8, 2026
The contribution of rare germline variants to the immune landscape of breast cancerFelipe Rojas-Rodríguez, Sander Canisius, Renske Keeman, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Pageof 5